Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo

Nature Medicine

Volumn 3, Issue 6, 1997, Pages 686-690

  Lu, Xian Ping ^a   Fanjul, Andrea ^a,c   Picard, Nathalie ^a   Pfahl, Michaela ^a   Rungta, Deepa ^a   Nared Hood, Karen ^a   Carter, Bruce ^c   Piedrafita, Javier ^b   Tang, Shiping ^b   Fabbrizio, Eric ^b   Pfahl, Magnus ^a,c  

^a Galderma Research Inc   (United States)

^b SIDNEY KIMMEL CANCER CENTER   (United States)

^c MAXIA Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; MX 28701; MX 33501; MX 901; RETINOIC ACID RECEPTOR; RETINOID; RETINOID DERIVATIVE; RETINOID RELATED MOLECULE; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, RETINOIC ACID; RETINOIDS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 16944366824     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0697-686     Document Type: Article

References (24)

1. Ginsberg, R.J., Kris, M.G. & Armstrong, J.G. Non-small cell lung cancer. in Cancer: Principles & Practice of Oncology, 4th edn., Vol. 1. (ed. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 673-713 (Lippincott, Philadelphia, 1993).
2. Hong, W.K. et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323, 795-801 (1991).
3. Huang, M.-E. et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567-572 (1988).
4. Castaigne, S. et al. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. Blood 76, 1704-1709 (1990).
5. Pfahl, M. Retinoids: Concepts for separation of desirable and undesirable effects in the treatment or prevention of cancer. in Hormones and Cancer. (ed. Vedeckis, W.V.) 127-146 (Birkhauser, Boston, MA, 1996).
6. Chambon, P. The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol. 5, 115-125 (1994).
7. Mangelsdorf, D.J. et al. The nuclear receptor superfamily: The second decade. Cell 83, 835-839 (1995).
8. Pfahl, M. et al. Nuclear retinoid receptors and their mechanisms of action. in Vitamins and Hormones, Vol. 49 (ed. G. Litwac) 327-382 (Academic Press, San Diego, CA, 1994).
9. La Vista-Picard, N., Hobbs, P.D., Pfahl, M., Dawson, M.I. & Pfahl, M. The receptor-DNA complex determines the retinoid response: A mechanism for the diversification of the ligand signal. Mol. Cell. Biol. 16, 4137-4146 (1996).
10. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocr. Rev. 5, 651-658 (1993).
11. Lehmann, J.M., Dawson, M.I., Hobbs, P.D., Husmann, M. & Pfahl, M. Identification of retinoids with nuclear receptor subtype selective activities. Cancer Res. 52, 4804-4809 (1991).
12. Graupner, G. & Pfahl, M. (1991). 6′-Substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands: A selection by transcriptional activation assay. Biochem. Biophys. Res. Commun. 179, 1554-1561 (1991).
13. Delescluse, C. et al. Selective high affinity retinoic acid receptor a or β-γ ligands. Mol. Pharmacol. 40, 556-562 (1991).
14. Fanjul, A. et al. A novel class of retinoids with selective anti-AP-1 activity exhibit anti-proliferative activity. Nature 372, 107-111 (1994).
15. Lehmann, J.M. et al. Retinoids selective for retinoid X receptor response pathways. Science 258, 1944-1946 (1992).
16. Weinstein, J.N. et al. An information-intensive approach to the molecular pharmacology of cancer. Science 275, 343-349 (1997).
17. Lotan, R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res. 54, 1987-1990 (1994).
18. Martin, S.J. & Green, D.R. Protease activation during apoptosis: Death by a thousand cuts? Cell 82, 349-352 (1995).
19. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. p53-dependent apoptosis modulates the cytoxicity of anticancer agents. Cell 74, 957-967 (1993).
20. Fanjul, A.N. et al. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem. 271, 22441-22446 (1996).
21. Delia, D. et al. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood 85, 359-367 (1995).
22. Benbrook, D., Lernhardt, W. & Pfahl, M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333, 669-672 (1988).
23. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849 (1993).
24. Shroot, B., Eustache, J. & Bernardon, J.-M. Benzimidazole derivatives and their therapeutic and cosmetic use. US Patent 4920140 (1990).